Free shipping on all orders over $ 500

XR9051 hydrochloride 

Cat. No. M28889

All AbMole products are for research use only, cannot be used for human consumption.

XR9051 hydrochloride  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

XR9051 hydrochloride is an orally active and specific modulator of P-glycoprotein-mediated multidrug resistance (MDR).

Chemical Information
Molecular Weight 679.2
Formula C39H39ClN4O5
CAS Number 180422-22-4
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Related P-glycoprotein Products
LY335979 trihydrochloride

LY335979 (Zosuquidar trihydrochloride) is a selective Pgp (P-glycoprotein) inhibitor with a Ki of 59 nM. *The compound is unstable in solutions, freshly prepared is recommended

Biricodar

The pipecolinate derivative Biricodar (VX-710, Incel) is a clinically applicable modulator of P-glycoprotein (Pgp) with potential chemosensitizing activity.

Tariquidar

Tariquidar (XR9576) is a selective, highly efficacious third generation P-glycoprotein (P-gp) inhibitor.

(20S)-Protopanaxadiol

(20S)-Protopanaxadiol (aPPD) is one of the aglycones of the ginsenosides and has a wide range of pharmacological activities.

Tenacissoside-G

Tenacissoside G is a C21 steroid from the stem of Marsdenia tenacissima. Tenacissoside G reverses multidrug resistance in multidrug resistant cancer cells that overexpress p-glycoprotein (Pgp).

  Catalog
Abmole Inhibitor Catalog




Keywords: XR9051 hydrochloride  supplier, P-glycoprotein, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.